Hostname: page-component-7bb8b95d7b-lvwk9 Total loading time: 0 Render date: 2024-09-12T11:18:39.530Z Has data issue: false hasContentIssue false
  • English
  • Français

Establishing cost-effectiveness of antipsychotic drugs

Published online by Cambridge University Press:  03 January 2018

David M. Taylor
David M. Taylor*
Affiliation:
Bethlem and Maudsley NHS Trust, Maudsley Hospital, Denmark Hill, London SE5 8AZ
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 171 , Issue 5 , November 1997 , pp. 486
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

References

Aitchison, K. J. & Kerwin, R. W. (1997) Cost-effectiveness of clozapine: a UK clinic-based study. British Journal of Psychiatry. 171, 125–130.Google Scholar
Robert, G. & Kennedy, P. (1997) Establishing cost-effectiveness of atypical neuroleptics. British Journal of Psychiatry, 171, 103–104.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.